You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 16, Issue 21

November-1 2024 - 165 articles

Cover Story: Improving knowledge in AML immunobiology may translate to better clinical developments in immunotherapies for patients with AML. Harnessing the immune system against leukemia cells can be a powerful treatment strategy for AML patients. Immune-based therapies such as BiTE and CAR-T cell therapy have proven to be effective means of targeting chemotherapy resistance in AML, but their therapeutic benefits are not durable and limited only to a fraction of patients. However, despite these limitations, recent studies have shown the peculiar sensitivity of some AML subtypes to immunotherapy, such as multiplex antigen targeting, and have provided the basis for future studies, thus holding the promise of successful clinical developments. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (165)

  • Article
  • Open Access
1 Citations
1,575 Views
11 Pages

Whole Exome-Wide Association Identifies Rare Variants in APC Associated with High-Risk Colorectal Cancer in the Middle East

  • Abdul Khalid Siraj,
  • Rong Bu,
  • Saud Azam,
  • Zeeshan Qadri,
  • Kaleem Iqbal,
  • Sandeep Kumar Parvathareddy,
  • Fouad Al-Dayel and
  • Khawla S. Al-Kuraya

4 November 2024

Background: Colorectal cancer (CRC) displays a complex pattern of inheritance. It is postulated that much of the missing heritability of CRC is enriched in high-impact rare alleles, which might play a crucial role in the etiology and susceptibility o...

  • Article
  • Open Access
6 Citations
2,242 Views
15 Pages

The Immunomodulatory Effect of Different FLT3 Inhibitors on Dendritic Cells

  • Sebastian Schlaweck,
  • Alea Radcke,
  • Sascha Kampmann,
  • Benjamin V. Becker,
  • Peter Brossart and
  • Annkristin Heine

4 November 2024

Background: FMS-like tyrosine kinase 3 (FLT3) mutations or internal tandem duplication occur in 30% of acute myeloid leukemia (AML) cases. In these cases, FLT3 inhibitors (FLT3i) are approved for induction treatment and relapse. Allogeneic hematopoie...

  • Systematic Review
  • Open Access
4 Citations
1,939 Views
13 Pages

Untreated Vestibular Schwannoma: Analysis of the Determinants of Growth

  • Cheng Yang,
  • Daniel Alvarado,
  • Pawan Kishore Ravindran,
  • Max E. Keizer,
  • Koos Hovinga,
  • Martinus P. G. Broen,
  • Henricus (Dirk) P. M. Kunst and
  • Yasin Temel

4 November 2024

The growth rate of sporadic VS varies considerably, posing challenges for consistent clinical management. This systematic review examines data on factors associated with VS growth, following a protocol registered in the PROSPERO database. The analysi...

  • Article
  • Open Access
1 Citations
1,782 Views
13 Pages

ZNF281 Facilitates the Invasion of Cervical Cancer Cell Both In Vivo and In Vitro

  • Ye Chong,
  • Kun Zhang,
  • Yuting Zeng,
  • Qian Chen,
  • Qian Feng,
  • Nan Cui,
  • Pengsheng Zheng,
  • Litao Ruan and
  • Wei Hua

4 November 2024

Background: Cervical cancer is the fourth most common cancer among women worldwide. The zinc finger transcription factor 281 (ZNF281)/ZBP-99 protein specifically binds to GC-rich DNA sequences and regulates gene expression, and it has been shown to p...

  • Review
  • Open Access
2 Citations
3,900 Views
15 Pages

4 November 2024

Background: Similar in histological characteristics and clinical manifestations, bronchiolitis obliterans syndrome (BOS) can develop following lung transplantation (LTx) or hematopoietic cell transplantation (HCT). In contrast to lung transplantation...

  • Review
  • Open Access
6 Citations
4,835 Views
20 Pages

Progress in Precision Medicine for Head and Neck Cancer

  • Sanaz Vakili,
  • Amir Barzegar Behrooz,
  • Rachel Whichelo,
  • Alexandra Fernandes,
  • Abdul-Hamid Emwas,
  • Mariusz Jaremko,
  • Jarosław Markowski,
  • Marek J. Los,
  • Saeid Ghavami and
  • Rui Vitorino

4 November 2024

This paper presents a comprehensive comparative analysis of biomarkers for head and neck cancer (HNC), a prevalent but molecularly diverse malignancy. We detail the roles of key proteins and genes in tumourigenesis and progression, emphasizing their...

  • Feature Paper
  • Article
  • Open Access
2 Citations
3,817 Views
11 Pages

Serum CYFRA 21-1 as a Prognostic Marker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors

  • Keiki Miyadera,
  • Sho Kakuto,
  • Mayu Sugai,
  • Ryosuke Tsugitomi,
  • Yoshiaki Amino,
  • Ken Uchibori,
  • Noriko Yanagitani,
  • Hisatoshi Sugiura,
  • Masahiro Seike and
  • Makoto Nishio
  • + 1 author

4 November 2024

Background: A prognostic marker in patients with non-small-cell lung cancer (NSCLC) treated with anti-PD-1/PD-L1 antibodies must be established. This study explored serum cytokeratin fraction 21–1 (CYFRA 21-1), which represents a squamous cell...

  • Systematic Review
  • Open Access
5 Citations
4,371 Views
15 Pages

The Prognostic Value of the 31-Gene Expression Profile Test in Cutaneous Melanoma: A Systematic Review and Meta-Analysis

  • Ryan A. Durgham,
  • Sami I. Nassar,
  • Ramazan Gun,
  • Shaun A. Nguyen,
  • Ameya A. Asarkar and
  • Cherie-Ann O. Nathan

4 November 2024

Background: Cutaneous melanoma is an increasingly common and potentially lethal form of skin cancer. Current staging systems based on clinical and pathological features have limitations in accurately predicting outcomes, particularly for early-stage...

  • Article
  • Open Access
2 Citations
1,794 Views
18 Pages

Primitive Resectable Small Bowel Cancer Clinical–Pathological Analysis: A 10-Year Retrospective Study in a General Surgery Unit

  • Cosmin Vasile Obleagă,
  • Costin Teodor Streba,
  • Cecil Sorin Mirea,
  • Ionică Daniel Vîlcea,
  • Dan Nicolae Florescu,
  • Mihai Călin Ciorbagiu,
  • Tudor Turcu,
  • Mirela Marinela Florescu,
  • Mircea Sebastian Șerbănescu and
  • Alina-Maria Mehedințeanu
  • + 1 author

4 November 2024

Introduction: Small bowel cancer is very rare; although the incidence of adenocarcinoma and other anatomopathological forms has increased recently, the diagnosis and treatment of this disease are still debatable because of the clinical heterogeneity...

  • Article
  • Open Access
2 Citations
2,992 Views
24 Pages

Enhancing Anti-PD-1 Immunotherapy by Targeting MDSCs via Hepatic Arterial Infusion in Breast Cancer Liver Metastases

  • Minhyung Kim,
  • Colin A. Powers,
  • Daniel T. Fisher,
  • Amy W. Ku,
  • Nickolay Neznanov,
  • Alfiya F. Safina,
  • Jianmin Wang,
  • Avishekh Gautam,
  • Siddharth Balachandran and
  • Anuradha Krishnamurthy
  • + 4 authors

3 November 2024

Background: Surgery, chemotherapy, and radiation often have limited utility for advanced metastatic disease in the liver, and despite its promising activity in select cancers, PD-1 blockade therapy similarly has minimal benefit in this setting. Curax...

of 17

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694